Rapidity of hematoma resolution after fibrinolytic therapy for intracerebral hemorrhage has a favorable effect on functional outcome

Abstract Fibrinolytic therapy with tissue plasminogen activator (rtPA) is considered a promising treatment option for intracerebral hemorrhage (ICH), but a large randomized controlled study (i.e., MISTIE III) failed to show a benefit for the long-term outcome. This study investigated whether the rap...

Full description

Saved in:
Bibliographic Details
Main Authors: Vesna Malinova, Regina Schwiddessen, Christian von der Brelie, Dorothee Mielke, Veit Rohde
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-00469-6
Tags: Add Tag
No Tags, Be the first to tag this record!